MyAverix Finance MyAverix Finance

XETRA · Healthcare

Formycon AG (FYB)

Biotechnology

Formycon AG (FYB) is listed on XETRA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for FYB

P/E ratio
25.00

Formycon AG (FYB) — FAQ

What is FYB's P/E ratio?

The price-to-earnings (P/E) ratio for Formycon AG (FYB) is 25.00 (data as of 2026-05-24).

Does Formycon AG pay a dividend?

Dividend yield is not available in the current snapshot for Formycon AG (FYB). Check the MyAverix Finance app for the latest dividend data.

What sector is Formycon AG in?

Formycon AG (FYB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is FYB listed on?

FYB is listed on XETRA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play